S

Scope Fluidics SA
WSE:SCP

Watchlist Manager
Scope Fluidics SA
WSE:SCP
Watchlist
Price: 165 PLN 2.87%
Market Cap: 450.5m PLN

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Scope Fluidics SA

Revenue
117k PLN
Cost of Revenue
-1.1m PLN
Gross Profit
-1m PLN
Operating Expenses
-34.4m PLN
Operating Income
-35.4m PLN
Other Expenses
96.7m PLN
Net Income
61.3m PLN

Margins Comparison
Scope Fluidics SA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
PL
Scope Fluidics SA
WSE:SCP
449.8m PLN
-871%
-30 248%
52 363%
US
Abbott Laboratories
NYSE:ABT
231.4B USD
56%
17%
32%
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.5B USD
67%
28%
28%
US
Boston Scientific Corp
NYSE:BSX
153.6B USD
69%
19%
12%
US
Stryker Corp
NYSE:SYK
150.8B USD
65%
22%
12%
IE
Medtronic PLC
NYSE:MDT
114.6B USD
66%
20%
14%
DE
Siemens Healthineers AG
XETRA:SHL
53.7B EUR
39%
14%
9%
US
Becton Dickinson and Co
NYSE:BDX
50.9B USD
45%
13%
7%
US
Edwards Lifesciences Corp
NYSE:EW
46.4B USD
79%
28%
75%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
43.7B USD
61%
29%
23%
US
Resmed Inc
NYSE:RMD
37.9B USD
59%
32%
26%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Scope Fluidics SA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
PL
Scope Fluidics SA
WSE:SCP
449.8m PLN
59%
48%
-29%
-147%
US
Abbott Laboratories
NYSE:ABT
231.4B USD
31%
18%
12%
21%
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.5B USD
16%
14%
15%
18%
US
Boston Scientific Corp
NYSE:BSX
153.6B USD
10%
5%
10%
8%
US
Stryker Corp
NYSE:SYK
150.8B USD
14%
7%
15%
11%
IE
Medtronic PLC
NYSE:MDT
114.6B USD
9%
5%
8%
7%
DE
Siemens Healthineers AG
XETRA:SHL
53.7B EUR
11%
4%
9%
6%
US
Becton Dickinson and Co
NYSE:BDX
50.9B USD
6%
3%
6%
5%
US
Edwards Lifesciences Corp
NYSE:EW
46.4B USD
49%
37%
15%
18%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
43.7B USD
59%
27%
51%
32%
US
Resmed Inc
NYSE:RMD
37.9B USD
26%
18%
25%
21%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less